Eliana Clark, EVP, Chief Technical Officer at Intellia Therapeutics, Inc. (NTLA), sold 3,720 shares at $37.21 ($139K) on 2023-01-04, disclosed to the SEC on 2023-01-06.
Open-market sale of $139k NTLA by EVP, Chief Technical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $51.74 | 105 | $5K | 3.9% |
| 2 | $34.48 | 231 | $8K | 5.7% |
| 3 | $37.21 | 1,692 | $63K | 45.2% |
| 4 | $37.21 | 1,692 | $63K | 45.2% |
| Total | $37.45 avg | 3,720 | $139K | 100% |
| Filing → |
| NTLA | SELL | 2025-07-03 | $10K | — | Filing → |
| NTLA | SELL | 2025-03-04 | $6K | — | Filing → |
| NTLA | SELL | 2025-01-06 | $187K | — | Filing → |